Author:
Wardani Yulia Fatma,Triasih Rina,Setyati Amalia
Abstract
Background Exhaled carbon monoxide has been related to the degree of inflammation. An easy, inexpensive, and non-invasive test to measure exhaled CO levels (eCO) may help in supporting the diagnosis of asthma and allergic rhinitis (AR) in children.
Objective To compare the eCO levels in children with asthma, AR, or both asthma and AR, to children without asthma or AR.
Methods This was a cross-sectional study involving 450 children aged 13-14 years in Yogyakarta. Asthma and AR were determined according to the International Study of Asthma and Allergies in Childhood (ISAAC) study criteria, while eCO level was examined using a Smokerlyzer®. The levels of eCO between groups were analyzed using Kruskal-Wallis and Mann-Whitney tests.
Results Of 450 children, 48 (10.67%) had asthma only, 91 (20.22%) had AR only, 67 (14.89%) had both asthma and AR, and 244 (54.22%) had neither asthma nor AR. The eCO levels of children with asthma or AR were not significantly different compared to those without asthma and AR (P=0.33 and P=0.19, respectively). However, children with both asthma and AR had significantly higher eCO level compared to children without asthma and AR (P< 0.001).
Conclusion The levels of eCO in children with asthma only or AR only are similar to those without both diseases. Children with both asthma and AR have significant higher eCO compared to healthy children.
Publisher
Paediatrica Indonesiana - Indonesian Pediatric Society
Subject
Pediatrics, Perinatology and Child Health
Reference22 articles.
1. 1. Pawankar R. Allergic diseases and asthma: a global public health concern and a call to action. World Allergy Organ J. 2014;7:12. DOI: 10.1186/1939-4551-7-12.
2. 2. Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368:733-43. DOI: 10.1016/S0140-6736(06)69283-0.
3. 3. Lai CKW, Beasley R, Crane J, Foliaki S, Shah J, Weiland S, et al. Global variation in the prevalence and severity of asthma symptoms?: phase three of the International Study of Asthma and Allergies in Childhood ( ISAAC ). Thorax. 2009;64:476-83. DOI:10.1136/thx.2008.106609.
4. 4. GINA. Global Strategy for Asthma Management and Prevention. Glob Strateg Asthma Manag Prev [Internet]. [cited 2019 Jun 13]. 2018;32. Available from: https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-tracked_v1.3.pdf
5. 5. Badan Penelitian dan Pengembangan Kesehatan, Kemenkes RI. Laporan Nasional RISKESDAS 2017. [cited 2019 Jun 13]. Available from: https://www.litbang.kemkes.go.id/laporan-riset-kesehatan-dasar-riskesdas/